Management of atypical uremic hemolytic syndrome in pregnant patient.
Rev Esp Anestesiol Reanim (Engl Ed)
; 69(4): 245-248, 2022 04.
Article
em En
| MEDLINE
| ID: mdl-35537944
ABSTRACT
Atypical uremic haemolytic syndrome is a variant of thrombotic micro-andiopathy characterized by non-autoimmune hemolytic anemia, thrombocytopenia and acute renal failure as a result of excessive activation of the complement. Up to 60% of patients have mutations in the genes that encode the complement system. A disensing factor is required for its manifestation, including gestation. It is an entity with a high morbidity, which can decrease drastically if an early diagnosis is made and appropriate treatment is initiated. Administration of ecuilizumab has demonstrated rapid process disruption, reducing the need for extrarenal purification therapies and improving renal function and patient prognosis.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Injúria Renal Aguda
/
Síndrome Hemolítico-Urêmica Atípica
/
Anemia Hemolítica
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Screening_studies
Limite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Rev Esp Anestesiol Reanim (Engl Ed)
Ano de publicação:
2022
Tipo de documento:
Article